Canine EPI: TLI Diagnosis, Enzymes and Cobalamin

Bottom line

Confirm suspected canine exocrine pancreatic insufficiency (EPI) with serum trypsin-like immunoreactivity (TLI), then manage pancreatic enzyme replacement and cobalamin together. [1] Interpret results using the performing laboratory's current assay thresholds; improvement during an enzyme trial alone does not establish EPI. [2]

Recognizing the maldigestion pattern

Weight loss with loose, voluminous feces and often polyphagia is the typical clinical pattern. Vomiting or anorexia can indicate concurrent disease. [1] Record intake, weight trajectory, muscle condition, stool character, and previous treatment before testing.

Keep the differential broad when hypoalbuminemia, effusion, or other abnormalities do not fit uncomplicated maldigestion. The canine protein-losing enteropathy workup addresses localization of protein loss and biopsy timing; that is a separate decision from confirming deficient pancreatic enzyme output.

Interpreting TLI without using an obsolete cutoff

The Texas A&M Gastrointestinal Laboratory currently classifies canine TLI at or below 5.5 µg/L as diagnostic for EPI with its assay. Its 5.6–7.5 µg/L category cannot exclude EPI; in symptomatic dogs it recommends considering an enzyme trial and/or repeat fasted testing in 1–2 months. Values of 7.6–10.8 µg/L are subnormal but EPI is unlikely. [2]

These are assay-specific instructions. Confirm the laboratory, fasting requirements, and reported interpretation before borrowing thresholds from an older publication. Texas A&M also states that oral pancreatic extracts do not interfere with serum TLI measurement, so enzyme withdrawal is unnecessary for testing. [2]

Selecting enzymes and measuring response

Formulation comparisons require attention to the actual comparator. In a blinded randomized trial, an enteric-coated preparation produced greater weight gain than the otherwise identical preparation without its coating. Clinical severity scores improved in both groups without a between-group difference. [3]

The authors explicitly caution that this does not demonstrate superiority over other commercially available uncoated products, including powders. Diet was not standardized, and follow-up was limited. [3] A product-level result should not become a claim that every coated preparation outperforms every powder.

Document product, administration with food, adherence, intake, stool response, and serial body weight using consistent measurements. Judge nutritional recovery as well as apparent diarrhea control. Do not change several components simultaneously without recording why.

Cobalamin is a treatment decision

The canine exocrine pancreas is an important source of intrinsic factor, and EPI can impair cobalamin absorption. Low serum cobalamin can also accompany ileal disease, dysbiosis, or inherited disorders; it is not an EPI-specific diagnostic marker. [4]

Assess cobalamin status and arrange supplementation and reassessment when indicated. Serum concentration and cellular deficiency are not identical: methylmalonic acid can help assess intracellular status, but renal insufficiency can increase it independently. [4] Interpret the result with renal function and the laboratory's reference interval.

Incomplete response: review before escalation

Recheck the diagnosis, actual enzyme delivery, nutritional adequacy, and cobalamin plan before adding medication. Concurrent small intestinal disease can explain poor response despite enzymes and cobalamin. Routine low-fat feeding is not recommended solely because EPI impairs fat digestion. [1]

Choose dietary changes around the individual's response and concurrent disease. A PLE-associated dietary indication should not automatically be transferred to EPI.

Do not turn persistent loose stool into an automatic antimicrobial indication. The metronidazole evidence reference reviews the separate evidence and harms relevant to that prescribing decision. Set a reassessment plan that distinguishes treatment delivery failure, nutritional failure, and a second disease.

Frequently Asked Questions

Does improvement on pancreatic enzymes confirm EPI?

No. Some dogs with small intestinal disease without EPI partially respond to enzymes. Interpret serum TLI and the clinical context. [2]

Which canine TLI cutoff should be used?

Use the performing laboratory’s current assay interpretation. Texas A&M currently lists ≤5.5 µg/L as diagnostic with its assay. [2]

Must enzymes be stopped before TLI testing?

No. Texas A&M states that oral pancreatic extracts do not affect serum TLI concentrations. [2]

Did the coating trial prove coated products beat powders?

No. It compared a coated preparation with the same preparation lacking the coating; the authors caution against extrapolation to other products. [3]

Does low cobalamin diagnose EPI?

No. Ileal disease, dysbiosis, and inherited disorders can also cause low cobalamin. [4]

Can renal disease affect methylmalonic acid interpretation?

Yes. Renal insufficiency can increase methylmalonic acid independently of primary cobalamin deficiency. [4]

Is dietary fat restriction mandatory in EPI?

No. Routine fat restriction solely for EPI is not recommended in the professional clinical review. [1] Individualize for concurrent disease.